Dalteparin Subcutaneous and Moxetumomab Pasudotox-tdfk
Determining the interaction of Dalteparin Subcutaneous and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dalteparin
Brand name: Fragmin
Synonyms: Dalteparin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dalteparin Subcutaneous-Moxetumomab pasudotox-tdfk Intravenous
- Dalteparin Subcutaneous-Moxifloxacin
- Dalteparin Subcutaneous-Moxifloxacin (Systemic)
- Dalteparin Subcutaneous-Moxifloxacin Hydrochloride
- Dalteparin Subcutaneous-Moxifloxacin Injection
- Dalteparin Subcutaneous-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Dalvance
- Moxetumomab Pasudotox-tdfk-Danaparoid
- Moxetumomab Pasudotox-tdfk-Danaparoid Subcutaneous
- Moxetumomab Pasudotox-tdfk-Danazol
- Moxetumomab Pasudotox-tdfk-Danocrine
- Moxetumomab Pasudotox-tdfk-Dantrium